Midatech Pharma Plc (MTP)
NASDAQ:MTP

Midatech Pharma (MTP) Stock Price & Analysis

260 Followers

MTP Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.60 - $5.30
Previous Close$0.79
Volume63.02K
Average Volume (3M)38.20K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)£6.42M
Total Debt (Recent Filing)£713.00K
Price to Earnings (P/E)-0.4
Beta1.27
Next EarningsApr 26, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
EPS (TTM)-1.80
Shares Outstanding4,333,709
R-Squared0.05
Standard Deviation0.52
10 Day Avg. Volume69,436
30 Day Avg. Volume38,199
Price to Book (P/B)0.32
Price to Sales (P/S)0.16
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-0.70
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target UpsideN/A
Rating ConsensusN/A
Alpha-0.05
Number of Analyst Covering0


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

MTP FAQ

What was Midatech Pharma’s price range in the past 12 months?
Midatech Pharma lowest stock price was $0.60 and its highest was $5.30 in the past 12 months.
    What is Midatech Pharma’s market cap?
    Currently, no data Available
    When is Midatech Pharma’s upcoming earnings report date?
    Midatech Pharma’s upcoming earnings report date is Apr 26, 2023 which is in 79 days.
      How were Midatech Pharma’s earnings last quarter?
      Midatech Pharma released its earnings results on Sep 14, 2022. The company reported -$1.007 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.007.
        Is Midatech Pharma overvalued?
        According to Wall Street analysts Midatech Pharma’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Midatech Pharma pay dividends?
          Midatech Pharma does not currently pay dividends.
          What is Midatech Pharma’s EPS estimate?
          Midatech Pharma’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Midatech Pharma have?
          Midatech Pharma has 4,333,710 shares outstanding.
            What happened to Midatech Pharma’s price movement after its last earnings report?
            Midatech Pharma reported an EPS of -$1.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.429%.
              Which hedge fund is a major shareholder of Midatech Pharma?
              Currently, no hedge funds are holding shares in MTP

              ---

              Midatech Pharma Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -84.26%
              12-Months-Change

              Fundamentals

              Return on Equity
              -99.57%
              Trailing 12-Months
              Asset Growth
              2.86%
              Trailing 12-Months
              This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
              Learn more about TipRanks Smart Score

              Company Description

              Midatech Pharma Plc

              Midatech Pharma PLC is a part of the healthcare sector. As a pharmaceutical company, it focuses on commercializing and developing products in oncology and other therapeutic areas. The company has only one operating segment Pipeline Research and Development. The research and development activities involve the discovery and development of pharmaceutical products in the field of nanomedicine and sustained release technology.

              ---

              Forecast EPS vs Actual EPS


              Similar Stocks
              Company
              Price & Change
              Follow
              ValiRx plc
              HemoGenyx Pharmaceuticals Plc
              Genflow Biosciences Plc
              BiVictriX Therapeutics PLC
              Midatech Pharma

              Popular Stocks

              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis